Copyright
©The Author(s) 2025.
World J Transplant. Mar 18, 2025; 15(1): 99220
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.99220
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.99220
Table 4 Examples of some traditional and emerging therapies in kidney transplantation
Traditional therapies | Plasmapheresis |
Immunoadsorption | |
Intravenous immunoglobulin | |
Anti-CD20 monoclonal antibody rituximab | |
Complement inhibitors: Eculizumab, C1 INH | |
Proteasome inhibitors: Bortezomib | |
Emerging therapies | Carfilzomib |
Tocilizumab | |
Clazakizumab | |
Daratumumab | |
Belimumab | |
Imlifidase | |
Ofatumumab | |
Obinutuzumab | |
Inebilizumab |
- Citation: Abbas K, Mubarak M. Expanding role of antibodies in kidney transplantation. World J Transplant 2025; 15(1): 99220
- URL: https://www.wjgnet.com/2220-3230/full/v15/i1/99220.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i1.99220